The 1q21.3 region driver gene EFNA3 promotes disease progression via inhibition of lung adenocarcinoma cell apoptosis

被引:0
|
作者
Dong, Chenchen [1 ]
Li, Peng [1 ]
Wu, Yue [1 ]
Guo, Zhong [2 ]
He, Rui [3 ]
机构
[1] Qiqihar Med Univ, Affiliated Hosp 2, Ward Resp 2, 37 ZhongHua West Rd, Jianhua Dist 161000, Qiqihar, Peoples R China
[2] Qiqihar Med Univ, Affiliated Hosp 3, Dept Otorhinolaryngol Head & Neck Surg, Qiqihar, Peoples R China
[3] Qiqihar Med Univ, Affiliated Hosp 2, Dept Emergency, Qiqihar, Peoples R China
关键词
Lung adenocarcinoma; The Cancer Genome Atlas (TCGA); EFNA3; cell apoptosis; EXPRESSION; SPRR2A;
D O I
10.21037/tcr-22-979
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Lung adenocarcinoma (LUAD) is the leading cause of cancer deaths in the world. Therefore, it is necessary to explore the underlying mechanism of EFNA3 (a 1q21.3 region driver gene) in the progression of LUAD cells. Methods: Differentially-expressed genes (DEGs) in LUAD tissues were screened based on The Cancer Genome Atlas (TCGA) database. The gene copy number variations in the 1q21.3 region were clarified by copy number variation analysis. Genes associated with overall survival (OS) were identified by Kaplan Meier (KM) analysis. The intersection of the genes was used to obtain the driver genes. LUAD patients were grouped with driver gene expression, and the DEGs were identified. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis was used to identify the enrichment pathways of the driver genes. EFNA3 was knocked down using lentiviral infection in A549 and PC9 cell lines. The efficiencies of lentiviral infection were confirmed by RT-PCR (reverse transcription polymerase chain reaction). After EFNA3 knockdown, changes in cell viability were confirmed by the 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide (MTT) assay, changes in cell proliferation and apoptosis were confirmed by enzyme-linked immunosorbent assay (ELISA), while changes in the expression of apoptosis-related proteins (Bax and caspase 3) were confirmed by RT-PCR and western blot. Results: A total of 483 LUAD samples and 59 normal control samples were obtained from TCGA database, and 640 upregulated genes were identified. 154 genes with a coefficient of copy number variations greater than 10% in the 1q23.1 region and 1,247 genes that were significantly associated with patient OS were selected. The intersection results indicated that EFNA3 might be a driver gene of LUAD. KEGG enrichment analysis indicated that the DEGs were mainly enriched in apoptosis-related pathways. Cell experiments showed that after lentiviral knockdown of EFNA3, EFNA3 messenger RNA (mRNA) and protein expression was significantly reduced (P<0.05), cell viability was markedly reduced (P<0.05), LUAD cell apoptosis increased notably (P<0.05), and LUAD cell proliferation decreased significantly (P<0.05). After EFNA3 knockdown, the expression of apoptosis-related proteins (Bax and caspase3) and mRNA in LUAD cells increased markedly (P<0.05). Conclusions: As a driver gene in the progression of LUAD, EFNA3 mainly affects the progression of LUAD by regulating LUAD cell apoptosis.
引用
收藏
页码:1309 / 1320
页数:13
相关论文
共 50 条
  • [1] A novel driver gene RNA export1 (RAE1) promotes tumor progression via inhibition of apoptosis in colorectal cancer.
    Kobayashi, Yuta
    Masuda, Takaaki
    Otsu, Hajime
    Takeishi, Kazuki
    Yonemura, Yusuke
    Mizushima, Tsunekazu
    Eguchi, Hidetoshi
    Doki, Yuichiro
    Mori, Masaki
    Mimori, Koshi
    CANCER SCIENCE, 2021, 112 : 276 - 276
  • [2] PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3
    Qian-Wen Zheng
    Qian-Zhi Ni
    Bing Zhu
    Xin Liang
    Ning Ma
    Yi-Kang Wang
    Sheng Xu
    Hui-Jun Cao
    Ji Xia
    Feng-Kun Zhang
    Er-Bin Zhang
    Xiao-Song Qiu
    Xu-Fen Ding
    Lin Qiu
    Xi-Lin Zhang
    Zhao-Hui Dong
    Zhi-Gang Li
    Xue-Li Zhang
    Dong Xie
    Jing-Jing Li
    Oncogene, 2022, 41 : 4244 - 4256
  • [3] PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3
    Zheng, Qian-Wen
    Ni, Qian-Zhi
    Zhu, Bing
    Liang, Xin
    Ma, Ning
    Wang, Yi-Kang
    Xu, Sheng
    Cao, Hui-Jun
    Xia, Ji
    Zhang, Feng-Kun
    Zhang, Er-Bin
    Qiu, Xiao-Song
    Ding, Xu-Fen
    Qiu, Lin
    Zhang, Xi-Lin
    Dong, Zhao-Hui
    Li, Zhi-Gang
    Zhang, Xue-Li
    Xie, Dong
    Li, Jing-Jing
    ONCOGENE, 2022, 41 (36) : 4244 - 4256
  • [4] Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3
    Qian-Wen Zheng
    Qian-Zhi Ni
    Bing Zhu
    Xin Liang
    Ning Ma
    Yi-Kang Wang
    Sheng Xu
    Hui-Jun Cao
    Ji Xia
    Feng-Kun Zhang
    Er-Bin Zhang
    Xiao-Song Qiu
    Xu-Fen Ding
    Lin Qiu
    Xi-Lin Zhang
    Zhao-Hui Dong
    Zhi-Gang Li
    Xue-Li Zhang
    Dong Xie
    Jing-Jing Li
    Oncogene, 2023, 42 : 2655 - 2656
  • [5] TFAP2A Promotes Cell Progression and Suppresses Ferroptosis in Lung Adenocarcinoma via Activating Transcription of CST1
    Luan, Xinyu
    Peng, Xuxing
    Hui, Gang
    Wei, Zichun
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2025, 39 (01)
  • [6] PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3 (vol 41, pg 4244, 2022)
    Zheng, Qian-Wen
    Ni, Qian-Zhi
    Zhu, Bing
    Liang, Xin
    Ma, Ning
    Wang, Yi-Kang
    Xu, Sheng
    Cao, Hui-Jun
    Xia, Ji
    Zhang, Feng-Kun
    Zhang, Er-Bin
    Qiu, Xiao-Song
    Ding, Xu-Fen
    Qiu, Lin
    Zhang, Xi-Lin
    Dong, Zhao-Hui
    Li, Zhi-Gang
    Zhang, Xue-Li
    Xie, Dong
    Li, Jing-Jing
    ONCOGENE, 2023, 42 (35) : 2655 - 2656
  • [7] Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B
    Tomizawa, Y
    Sekido, Y
    Kondo, M
    Gao, BN
    Yokota, J
    Roche, J
    Drabkin, H
    Lerman, MI
    Gazdar, AF
    Minna, JD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) : 13954 - 13959
  • [8] SKA3 promotes lung adenocarcinoma progression via the EGFR/E2F1/SKA3/integrin β1 signaling loop
    Zheng, Xiufen
    Sun, Zedong
    Wang, Shi
    Liu, Qibing
    Zhu, Biqing
    Ren, Zhijian
    Fan, Dingwei
    Zhang, Chunping
    Fu, Xinyin
    Jin, Yan
    Luo, Jing
    Wang, Jie
    Ren, Binhui
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2025,
  • [9] Upregulation of CCT3 predicts poor prognosis and promotes cell proliferation via inhibition of ferroptosis and activation of AKT signaling in lung adenocarcinoma
    Kun Wang
    Jian He
    Changling Tu
    Hui Xu
    Xugang Zhang
    Yongchang Lv
    Chao Song
    BMC Molecular and Cell Biology, 23
  • [10] Upregulation of CCT3 predicts poor prognosis and promotes cell proliferation via inhibition of ferroptosis and activation of AKT signaling in lung adenocarcinoma
    Wang, Kun
    He, Jian
    Tu, Changling
    Xu, Hui
    Zhang, Xugang
    Lv, Yongchang
    Song, Chao
    BMC MOLECULAR AND CELL BIOLOGY, 2022, 23 (01)